Correlation Between Curis and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Curis and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curis and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Curis Inc and SAB Biotherapeutics, you can compare the effects of market volatilities on Curis and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curis with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curis and SAB Biotherapeutics.
Diversification Opportunities for Curis and SAB Biotherapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Curis and SAB is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Curis Inc and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Curis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curis Inc are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Curis i.e., Curis and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Curis and SAB Biotherapeutics
Given the investment horizon of 90 days Curis Inc is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Curis Inc is 1.42 times less risky than SAB Biotherapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 597.00 in SAB Biotherapeutics on November 5, 2024 and sell it today you would lose (382.00) from holding SAB Biotherapeutics or give up 63.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Curis Inc vs. SAB Biotherapeutics
Performance |
| Timeline |
| Curis Inc |
| SAB Biotherapeutics |
Curis and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Curis and SAB Biotherapeutics
The main advantage of trading using opposite Curis and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curis position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Curis vs. Artelo Biosciences | Curis vs. Histogen | Curis vs. X4 Pharmaceuticals | Curis vs. Mereo BioPharma Group |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |